FDA.reportPublic FDA data

eravacycline 50 MG Injection

RxCUI
2055911
RxNorm name
eravacycline 50 MG Injection
Display name
eravacycline 50 MG Injection
Full name
eravacycline 50 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XeravaERAVACYCLINETetraphase Pharmaceuticals, Inc.a4b188d4-f467-470c-ad7b-25ffbdd8862a2025-03-31Warnings, Adverse reactionsExact identifier
rxcui: 2055911

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a4b188d4-f467-470c-ad7b-25ffbdd8862aeravacycline 50 MG Injection [PSN] · eravacycline 50 MG Injection [SCD] · eravacycline 50 MG (equivalent to eravacycline dihydrochloride 63.5 MG) Injection [SY]311These highlights do not include all the information needed to use XERAVA safely and effectively. See full prescribing information for XERAVA. XERAVA ® (eravacycline) for injection, for intravenous use Initial U.S. Approval: 201820250922